Addressing the global challenges of COVID-19 and other pulmonary diseases with microfluidic technology.
Engineering (Beijing)
; 2022 Jan 27.
Article
in English
| MEDLINE | ID: covidwho-1654384
ABSTRACT
COVID-19, an infectious pulmonary disease caused by the SARS-CoV-2 virus, has profoundly impacted the world, motivating researchers across a broad spectrum of academic disciplines to gain a deeper understanding and develop effective therapies to this disease. This article presents an engineering perspective on how microfluidic technologies may address some of the challenges presented by COVID-19 and other pulmonary diseases. In particular, this article highlights urgent needs in pulmonary medicine, with an emphasis on technological innovations in the microfluidic manipulation of particles and fluids, and how these innovations may contribute to the study, diagnosis, and therapy of pulmonary diseases.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Language:
English
Year:
2022
Document Type:
Article
Affiliation country:
J.eng.2022.01.003
Similar
MEDLINE
...
LILACS
LIS